Kloos, Robin Q H <br/><br/>
Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model.  [electronic resource] 

 -  Haematologica  05 2021 
 - 1254-1261 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2019.242289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Asparaginase<br/>Child<br/>Databases, Factual<br/>Drug Monitoring<br/>Humans<br/>Models, Biological<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy